Search - tctmd.com

Displaying 581 - 600 of 620

Sort: Relevancy | Date

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

Jason Kahn

May 22, 2013

News Daily News

Colchicine Reduces BMS Restenosis in Diabetic Patients

April 19, 2013

News Daily News

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

April 19, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

News Daily News

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

Jason Kahn

March 25, 2013

News Daily News

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

Caitlin E. Cox

February 07, 2013

News Daily News

Endovascular Therapy Promising for Critical Limb Ischemia

L.A. McKeown

February 07, 2013

News Daily News

Self-Expanding Nitinol Stent Potential Option in Popliteal Artery Disease

January 24, 2013

News Daily News

Su Publica el PACIFIER: Los Balones liberadores de Fármacos Ayudan a tratar las Lesiones Femoropoplíteas

Caitlin E. Cox

December 09, 2012

News Daily News

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Caitlin E. Cox

December 09, 2012

News Daily News

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Caitlin E. Cox

November 15, 2012

Presentation TCT 2012

Current and Future Clinical Applications of Drug-Coated Balloons: From Bench to Bedside

Presenter: Bruno Scheller

October 26, 2012

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

Presentation TCT 2012

Drug-Coated Balloons and Atherectomy: Additive, Synergistic, or Without Advantage?

Presenter: Luigi Salemme

October 22, 2012

News Industry News

Vascular Nanotransfer Technologies (“VNT”) reports in vivo results for its paclitaxel nano-carrier based drug coated balloon (DCB) technology

October 19, 2012

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Jason Kahn

October 05, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Caitlin E. Cox

August 29, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Industry News

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

July 03, 2012

Advertisement

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

Colchicine Reduces BMS Restenosis in Diabetic Patients

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

Endovascular Therapy Promising for Critical Limb Ischemia

Self-Expanding Nitinol Stent Potential Option in Popliteal Artery Disease

Su Publica el PACIFIER: Los Balones liberadores de Fármacos Ayudan a tratar las Lesiones Femoropoplíteas

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Current and Future Clinical Applications of Drug-Coated Balloons: From Bench to Bedside

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Drug-Coated Balloons and Atherectomy: Additive, Synergistic, or Without Advantage?

Vascular Nanotransfer Technologies (“VNT”) reports in vivo results for its paclitaxel nano-carrier based drug coated balloon (DCB) technology

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content